I've been buying NAL from 62c to 57c today. Would any current holders or previous holders of the stock care to comment where to from here for the share price. The company appears fundamentally sound with their holding in Norwood Immunology, cash and expected 2nd half revenue from Eyecare. Additionally the eminent physicians/directors and US hospitals involved in the US trials are worlds best.
I regret if this sounds like a ramp but I would imagine that Norwood Abbey at these prices or lower could prove a tempting target for a couple of Australian or any one of a number overseas Bio/Pharma companies.
Anyone care to comment?
- Forums
- ASX - By Stock
- NAL
- bounce, takeover or down from here?
bounce, takeover or down from here?
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online